Elevated GRHL2 can play a disproportionate role in breast cancer progression with the coexistence of stem cell and dormancy behaviors supporting cellular plasticity for tumor initiation and resistance for ER-positive breast cancer cells. The gene discussed is GRHL2; the disease is breast carcinoma.